ORACLE INVESTMENT MANAGEMENT INC - Q1 2020 holdings

$337 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 35.0% .

 Value Shares↓ Weighting
QDEL BuyQUIDEL CORP$176,643,000
+34.0%
1,805,983
+2.8%
52.48%
+112.1%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$63,661,000
-39.2%
1,870,743
-2.7%
18.92%
-3.8%
AXDX SellACCELERATE DIAGNOSTICS INC$34,172,000
-52.0%
4,102,287
-2.6%
10.15%
-24.0%
AGEN BuyAGENUS INC$13,134,000
+16.4%
5,360,867
+93.4%
3.90%
+84.2%
SLNO  SOLENO THERAPEUTICS INC$9,212,000
-19.1%
3,870,6270.0%2.74%
+28.1%
VRML  VERMILLION INC$8,179,000
+2.8%
9,825,2890.0%2.43%
+62.7%
AMRN SellAMARIN CORP PLCspons adr new$7,343,000
-93.4%
1,835,639
-64.9%
2.18%
-89.6%
OPK BuyOPKO HEALTH INC$5,994,000
-6.8%
4,473,076
+2.3%
1.78%
+47.6%
QDEL SellQUIDEL CORPcall$3,877,000
+24.6%
157,400
-36.5%
1.15%
+97.3%
PACB BuyPACIFIC BIOSCIENCES CALIF IN$3,734,000
-34.6%
1,220,359
+9.9%
1.11%
+3.5%
ATRS BuyANTARES PHARMA INC$2,896,000
-10.5%
1,227,114
+78.3%
0.86%
+41.7%
MOTS  MOTUS GI HLDGS INC$2,565,000
-70.6%
3,806,6660.0%0.76%
-53.5%
BIOL  BIOLASE INC$1,940,000
-32.1%
5,173,2500.0%0.58%
+7.3%
BIIB  BIOGEN INC$1,540,000
+6.6%
4,8680.0%0.46%
+69.0%
CFRX NewCONTRAFECT CORP$742,000128,845
+100.0%
0.22%
YMAB NewY-MABS THERAPEUTICS INC$658,00025,212
+100.0%
0.20%
BHVN NewBIOHAVEN PHARMACTL HLDG CO Lcall$218,000100,000
+100.0%
0.06%
AXDX SellACCELERATE DIAGNOSTICS INCcall$55,000
-96.3%
388,400
-19.7%
0.02%
-94.3%
AMRN SellAMARIN CORP PLCcall$2,000
-100.0%
351,000
-82.1%
0.00%
-99.9%
DB ExitDEUTSCHE BANK AGnamen akt$0-25,000
-100.0%
-0.04%
CFRX ExitCONTRAFECT CORP$0-1,502,766
-100.0%
-0.18%
ABC ExitAMERISOURCEBERGEN CORP$0-25,000
-100.0%
-0.40%
DERM ExitDERMIRA INC$0-2,528,311
-100.0%
-7.20%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
OPKO HEALTH INC42Q3 202310.6%
PACIFIC BIOSCIENCES CALIF IN42Q3 202322.6%
BIOGEN INC42Q3 20230.6%
QUIDEL CORP36Q1 202252.5%
AMARIN CORP PLC31Q3 202123.1%
VERMILLION INC28Q1 20203.8%
AGENUS INC25Q3 20239.8%
TESARO INC23Q4 201827.8%
ACCELERATE DIAGNOSTICS INC23Q2 202323.0%
MAZOR ROBOTICS LTD20Q1 201818.0%

View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.

Compare quarters

Export ORACLE INVESTMENT MANAGEMENT INC's holdings